Skip to main content
Erschienen in: BMC Neurology 1/2017

Open Access 01.12.2017 | Erratum

Erratum to: A randomized double-blind multi-center trial of hydrogen water for Parkinson’s disease: protocol and baseline characteristics

verfasst von: Asako Yoritaka, Takashi Abe, Chigumi Ohtsuka, Tetsuya Maeda, Masaaki Hirayama, Hirohisa Watanabe, Hidemoto Saiki, Genko Oyama, Jiro Fukae, Yasushi Shimo, Taku Hatano, Sumihiro Kawajiri, Yasuyuki Okuma, Yutaka Machida, Hideto Miwa, Chikako Suzuki, Asuka Kazama, Masahiko Tomiyama, Takeshi Kihara, Motoyuki Hirasawa, Hideki Shimura, Nobutaka Hattori

Erschienen in: BMC Neurology | Ausgabe 1/2017

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN
Hinweise
The online version of the original article can be found under doi:10.​1186/​s12883-016-0589-0.

Erratum

After publication of the original article [1], it came to the authors’ attention that there was an error in the number of male and female participants. The correct number is 90 male and 88 female, not 89 male and 89 female as originally reported.
This error was present in the Methods section of the abstract and in Table 1.
Table 1
The baseline characteristics of the study participants
 
Mean
Std. Deviation
Age
64.2
9.2
Disease duration
6.8
4.5
Sex (male/female) n
90
88
Wearing off (+/−) n
58
120
Dyskinesia (+/−) n
42
136
Levodopa mg
344.1
202.8
Levodopa (+/−) n
154
24
Dopamine agonist levodopa equivalent dose (mg) [12]
166.3
121.1
Total levodopa equivalent dose (mg) [12]a
592.0
317.6
Unified Parkinson’s Disease Rating Scale
Part I
0.7
1.2
Part II
5.6
3.9
Part III
15.7
8.4
Part IV
1.7
2.2
Total
23.7
11.8
Modified Hoehn and Yahr stage
2.1
0.6
Parkinson’s disease Questionnaire-39
Mobility
10.4
9.1
Activities of daily living
5.2
5.1
Emotional well-being
6.0
4.4
Stigma
3.2
2.8
Social support
1.4
1.9
Cognitions
4.0
3.0
Communication
1.7
2.2
Body discomfort
2.5
2.6
Total
34.4
24.2
anot including istradefylline and zonisamide
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.
download
DOWNLOAD
print
DRUCKEN
Literatur
1.
Zurück zum Zitat Yoritaka A, Abe T, Ohatsuka C, et al. A randomized double-blind multi-center trial of hydrogen water for Parkinson’s disease: protocol and baseline characteristics. BMC Neurol. 2016;16:66.CrossRefPubMedPubMedCentral Yoritaka A, Abe T, Ohatsuka C, et al. A randomized double-blind multi-center trial of hydrogen water for Parkinson’s disease: protocol and baseline characteristics. BMC Neurol. 2016;16:66.CrossRefPubMedPubMedCentral
Metadaten
Titel
Erratum to: A randomized double-blind multi-center trial of hydrogen water for Parkinson’s disease: protocol and baseline characteristics
verfasst von
Asako Yoritaka
Takashi Abe
Chigumi Ohtsuka
Tetsuya Maeda
Masaaki Hirayama
Hirohisa Watanabe
Hidemoto Saiki
Genko Oyama
Jiro Fukae
Yasushi Shimo
Taku Hatano
Sumihiro Kawajiri
Yasuyuki Okuma
Yutaka Machida
Hideto Miwa
Chikako Suzuki
Asuka Kazama
Masahiko Tomiyama
Takeshi Kihara
Motoyuki Hirasawa
Hideki Shimura
Nobutaka Hattori
Publikationsdatum
01.12.2017
Verlag
BioMed Central
Erschienen in
BMC Neurology / Ausgabe 1/2017
Elektronische ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-017-0817-2

Weitere Artikel der Ausgabe 1/2017

BMC Neurology 1/2017 Zur Ausgabe